18F-FDG PET/CT or PET Role in MALT Lymphoma: An Open Issue not Yet Solved-A Critical Review.

Détails

ID Serval
serval:BIB_9BEA17D177B5
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
18F-FDG PET/CT or PET Role in MALT Lymphoma: An Open Issue not Yet Solved-A Critical Review.
Périodique
Clinical lymphoma, myeloma & leukemia
Auteur(s)
Albano D., Durmo R., Treglia G., Giubbini R., Bertagna F.
ISSN
2152-2669 (Electronic)
ISSN-L
2152-2669
Statut éditorial
Publié
Date de publication
03/2020
Peer-reviewed
Oui
Volume
20
Numéro
3
Pages
137-146
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Résumé
Mucosa-associated lymphoid tissue (MALT) lymphoma involves the mucosa-associated lymphoid tissue potentially arising from any mucosal site, with the stomach as the most common site of involvement. MALT lymphoma is not usually an aggressive disease with a good prognosis except for selected cases. Fluorine-18 ( <sup>18</sup> F) fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) is a noninvasive imaging tool used for staging, restaging, and evaluation of the treatment response in non-Hodgkin and Hodgkin lymphoma. However, its effective role in MALT lymphoma is not yet clear. The open question is whether these lymphomas are <sup>18</sup> F-FDG avid or not, with conflicting results reported in the literature. Consequently, the possible clinical role of <sup>18</sup> F-FDG PET/CT for staging and restaging purposes is under debate. The aim of the present review was to analyze the reported data about the role of <sup>18</sup> F-FDG PET or PET/CT in patients with MALT lymphoma. We performed a comprehensive computer literature search of the Scopus, Cochrane, PubMed/MEDLINE, and Embase databases, including articles reported up to August 2019. We included 32 studies that had analyzed <sup>18</sup> F-FDG PET or PET/CT for patients with MALT lymphoma. We analyzed the metabolic behavior of MALT lymphoma using <sup>18</sup> F-FDG PET and the effect of the PET findings in the staging, treatment response evaluation, and prognosis.
Mots-clé
(18)F-FDG, MALT, Marginal zone lymphoma, PET, PET/CT
Pubmed
Création de la notice
17/02/2020 15:55
Dernière modification de la notice
12/03/2020 6:26
Données d'usage